PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20124483-6	2010	Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion.	3,3"-diinodolylmethane	63-85	microRNA 146a	Homo sapiens	123-131	
20124483-6	2010	Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion.	3,3"-diinodolylmethane	63-85	epidermal growth factor receptor	Homo sapiens	171-175	
20124483-6	2010	Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion.	3,3"-diinodolylmethane	63-85	metastasis associated 1 family member 2	Homo sapiens	177-182	
20124483-6	2010	Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion.	3,3"-diinodolylmethane	63-85	interleukin 1 receptor associated kinase 1	Homo sapiens	184-190	
20124483-6	2010	Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion.	3,3"-diinodolylmethane	63-85	nuclear factor kappa B subunit 1	Homo sapiens	196-205	
20124483-6	2010	Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion.	1,4-dideoxy-1,4-iminomannitol	87-90	microRNA 146a	Homo sapiens	123-131	
20124483-6	2010	Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion.	1,4-dideoxy-1,4-iminomannitol	87-90	epidermal growth factor receptor	Homo sapiens	171-175	
20124483-6	2010	Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion.	1,4-dideoxy-1,4-iminomannitol	87-90	metastasis associated 1 family member 2	Homo sapiens	177-182	
20124483-6	2010	Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion.	1,4-dideoxy-1,4-iminomannitol	87-90	interleukin 1 receptor associated kinase 1	Homo sapiens	184-190	
20124483-6	2010	Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion.	1,4-dideoxy-1,4-iminomannitol	87-90	nuclear factor kappa B subunit 1	Homo sapiens	196-205	
20124483-6	2010	Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion.	Isoflavones	95-105	microRNA 146a	Homo sapiens	123-131	
20124483-6	2010	Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion.	Isoflavones	95-105	epidermal growth factor receptor	Homo sapiens	171-175	
20124483-6	2010	Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion.	Isoflavones	95-105	metastasis associated 1 family member 2	Homo sapiens	177-182	
20124483-6	2010	Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion.	Isoflavones	95-105	interleukin 1 receptor associated kinase 1	Homo sapiens	184-190	
20124483-6	2010	Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion.	Isoflavones	95-105	nuclear factor kappa B subunit 1	Homo sapiens	196-205